T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

Conditions: Glioblastoma Multiforme; Astrocytoma, Grade IV Interventions: Biological: Allogeneic cytomegalovirus-specific T cells; Drug: Pembrolizumab Sponsors: Queensland Institute of Medical Research; CUREator; Merck Sharp& Dohme LLC; The Newro Foundation; Royal Brisbane and Women ' s Hospital; Princess Alexandra Hospital, Brisbane, Australia; Austin Hospital, Melbourne Australia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials